Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Gelrud, A. A., Digenio, A., Alexander, V., Williams, K. R., Hsieh, A., Gouni-Berthold, I., Bruckert, E., Stroes, E., Geary, R., Hughes, S., Tsmikas, S., Witztum, J. L. and Gaudet, D. (2017). Treatment With Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients With Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (sHTG) vs Placebo: Results of the Approach and Compass Studies. Pancreas, 46 (10). S. 1402 - 1403. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1536-4828

Gouni-Berthold, I., Alexander, V., Digenio, A., DuFour, R., Steinhagen-Thiessen, E., Martin, S., Moriarty, P., Hughes, S., Jones, R., Witztum, J. L., Gaudet, D. and Stroes, E. (2017). Apolipoprotein C-III inhibition with volanesorsen in patients with hypertriglyceridemia (COMPASS): A randomized, double-blind, placebo-controlled trial. Atheroscler. Suppl., 28. S. E1 - 2. CLARE: ELSEVIER IRELAND LTD. ISSN 1878-5050

Stroes, E. S., van der Valk, F. M., Gaudet, D., Gouni-Berthold, I., Riksen, N. P., Steinhagen-Thiessen, E., Isermann, B., Nordestgaard, B., Viney, N. J., Marcovina, S., Hughes, S. G., Tami, J., Xia, S., Witztum, J. L. and Tsimikas, S. (2016). PREVALENCE OF LPA SINGLE NUCLEOTIDE POLYMORPHISMS AND ISOFORMS IN PATIENTS ENROLLED IN A PHASE 2 IONIS-APO(A)(RX) CLINICAL TRIAL. Atherosclerosis, 252. S. E123 - 1. CLARE: ELSEVIER IRELAND LTD. ISSN 1879-1484

This list was generated on Fri Feb 26 04:45:38 2021 CET.